Intervention
PP3M 525 mg eq.
ClinicalTrials.gov intervention label
Clinical trials
3 shownA Study of Paliperidone Palmitate 6-Month FormulationNCT03345342 · 2017-11-20
COMPLETEDA Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaNCT01529515 · 2012-05-01
COMPLETEDStudy of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaNCT01515423 · 2012-05-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED3
Phase mix
PHASE33
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.